论文部分内容阅读
目的:评价痰热清注射液辅助治疗儿童支气管肺炎的临床疗效。方法:选取2012年11月至2013年1月我院收治的支气管肺炎患儿161例,按治疗方案分为对照组74例和治疗组87例。对照组给予常规抗菌、抗病毒(利巴韦林)、退热、雾化吸入止咳化痰药治疗;治疗组在对照组基础上加用痰热清注射液0.3~0.5 m L/kg,静脉滴注1次/日。观察两组患儿症状体征恢复时间、治愈率、住院时间等。结果:治疗组治愈率93.10%(81/87),对照组治愈率93.24%(69/74),两组比较差异无统计学意义(P>0.05);治疗组平均住院时间(8.80±2.16)d短于对照组的(9.80±2.99)d(P<0.05);治疗组治愈患儿的发热、咳嗽、气促、缺氧、肺部啰音消失时间均短于对照组(P<0.05)。结论:痰热清注射液辅助治疗小儿支气管肺炎可有效缩短疗程,减少住院时间。
Objective: To evaluate the clinical efficacy of Tanreqing Injection in the treatment of bronchial pneumonia in children. Methods: 161 children with bronchial pneumonia admitted in our hospital from November 2012 to January 2013 were divided into control group (n = 74) and treatment group (n = 87) according to the treatment plan. The control group was given routine antibacterial, antiviral (ribavirin), antipyretic and aerosol inhalation, cough and phlegm medicine treatment. The treatment group was treated with Tanreqing Injection 0.3 ~ 0.5 m L / kg on the basis of the control group, Drip once / day. Two groups of children were observed symptoms and signs recovery time, cure rate, hospital stay and so on. Results: The cure rate was 93.10% (81/87) in the treatment group and 93.24% (69/74) in the control group, with no significant difference between the two groups (P> 0.05). The average length of stay in the treatment group was 8.80 ± 2.16 d was shorter than that of the control group (9.80 ± 2.99) d (P <0.05). The fever, cough, shortness of breath, hypoxia and pulmonary rales disappeared in the treatment group were shorter than those in the control group (P <0.05) . Conclusion: Tanreqing injection adjuvant treatment of children with bronchial pneumonia can shorten the course of treatment, reduce hospital stay.